Depo-Provera is a birth control shot that contains a synthetic hormone called progestin. It is one of the most effective forms of birth control available, but it has also been linked to a number of health risks, including cancer.
In 2020, a group of women filed a class-action lawsuit against Pfizer, the manufacturer of Depo-Provera, alleging that the drug caused them to develop breast cancer. The lawsuit is still ongoing, but it has raised concerns about the safety of Depo-Provera and whether women are being adequately warned about the risks.
What is the evidence linking Depo-Provera to cancer?
There is some evidence that Depo-Provera may increase the risk of breast cancer, especially in young women. A study published in the journal Cancer Epidemiology, Biomarkers & Prevention found that women who used Depo-Provera for more than a year had a 2.2-fold increased risk of developing breast cancer.
Another study, published in the journal JAMA Internal Medicine, found that women who used Depo-Provera for more than five years had a 3.5-fold increased risk of developing breast cancer.
However, it is important to note that these studies are observational, which means they cannot prove that Depo-Provera causes breast cancer. It is possible that there is another factor, such as genetics or lifestyle, that is causing the increased risk of cancer in women who use Depo-Provera.
What should women who have used Depo-Provera do?
If you have used Depo-Provera, you should talk to your doctor about the risks and benefits of the drug. If you are concerned about your risk of cancer, you may want to consider switching to another form of birth control.
Women who have used Depo-Provera should also be aware of the signs and symptoms of breast cancer. These include a lump in the breast, changes in breast size or shape, and discharge from the nipple. If you experience any of these symptoms, you should see your doctor right away.
Depo-Provera is an effective form of birth control, but it is important to be aware of the risks, including the potential risk of cancer. If you are concerned about your risk of cancer, you should talk to your doctor about other birth control options.
- Q: Can I sue Pfizer if I developed cancer after using Depo-Provera?
A: Yes, you may be able to sue Pfizer if you developed cancer after using Depo-Provera. However, you will need to prove that the drug caused your cancer. This can be difficult to do, but there are experienced attorneys who can help you.
- Q: How much money can I get if I win a Depo-Provera cancer lawsuit?
A: The amount of money you can get if you win a Depo-Provera cancer lawsuit will depend on a number of factors, including the severity of your injuries and the cost of your medical treatment. However, some people have received millions of dollars in compensation from Pfizer.
- Q: What are the deadlines for filing a Depo-Provera cancer lawsuit?
A: The deadlines for filing a Depo-Provera cancer lawsuit vary from state to state. However, most states have a statute of limitations that requires you to file your lawsuit within a certain period of time after you discover your injuries.
- Q: Can I file a Depo-Provera cancer lawsuit if I live outside the United States?
A: Yes, you may be able to file a Depo-Provera cancer lawsuit if you live outside the United States. However, you will need to find an attorney who is licensed to practice law in the United States.
- Q: What are the chances of winning a Depo-Provera cancer lawsuit?
A: The chances of winning a Depo-Provera cancer lawsuit vary from case to case. However, there have been a number of successful lawsuits against Pfizer.
- Q: How long does it take to settle a Depo-Provera cancer lawsuit?
A: The length of time it takes to settle a Depo-Provera cancer lawsuit can vary widely. However, most cases settle within a few years of being filed.
If you have any questions about Depo-Provera cancer lawsuits, you should contact an experienced attorney.
- Cancer Epidemiology, Biomarkers & Prevention: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564832/
- JAMA Internal Medicine: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/414710